"MicroGenDX is Introducing PerioDX, the First Commercially Available Saliva-Based qPCR+NGS Test for Oral Health"

Pancreatic Cancer and the Oral Microbiome

  1. Fan, Xiaozhou et al. “Human oral microbiome and prospective risk for pancreatic cancer: a population-based nested case-control study.” Gut vol. 67,1 (2018): 120-127. doi:10.1136/gutjnl-2016-312580
  2. Vogtmann E, Han Y, Caporaso JG, Bokulich N, Mohamadkhani A, Moayyedkazemi A, Hua X, Kamangar F, Wan Y, Suman S, Zhu B, Hutchinson A, Dagnall C, Jones K, Hicks B, Shi J, Malekzadeh R, Abnet CC, Pourshams A. Oral microbial community composition is associated with pancreatic cancer: A case-control study in Iran. Cancer Med. 2020 Jan;9(2):797-806. doi: 10.1002/cam4.2660. Epub 2019 Nov 21. PMID: 31750624; PMCID: PMC6970053. https://pubmed.ncbi.nlm.nih.gov/31750624/
  3.  Michaud DS, Izard J. Microbiota, oral microbiome, and pancreatic cancer. Cancer J. 2014 May-Jun;20(3):203-6. doi: 10.1097/PPO.0000000000000046. PMID: 24855008; PMCID: PMC4160879. https://pubmed.ncbi.nlm.nih.gov/24855008/
  4. Sethi V, Vitiello GA, Saxena D, Miller G, Dudeja V. The Role of the Microbiome in Immunologic Development and its Implication For Pancreatic Cancer Immunotherapy. Gastroenterology. 2019 May;156(7):2097-2115.e2. doi: 10.1053/j.gastro.2018.12.045. Epub 2019 Feb 12. PMID: 30768986. https://pubmed.ncbi.nlm.nih.gov/30768986/